Prograf Class Cert. Makes Case Unworkable, 1st Circ. Hears
Astellas Pharma US LLC pressed the First Circuit Monday to nix a ruling certifying a class of indirect purchasers who claim the drugmaker improperly delayed generic competition for the immunosuppressant drug...To view the full article, register now.
Already a subscriber? Click here to view full article